# Plant Monograph: Chaulmoogra Oil
**Name of plant:**
Chaulmoogra Oil
**Catch phrase (Carmina Gadelica or traditional invocation if available):**
No Carmina Gadelica or Gaelic invocation is recorded for this South Asian medicinal plant. A traditional descriptive phrase is fitting: **“The bitter seed that carried hope to the afflicted.”**
**Family:**
Achariaceae — formerly placed in Flacourtiaceae
**Genus and species:**
*Hydnocarpus pentandrus* (Buch.-Ham.) Oken
*Hydnocarpus wightianus* Blume is a historical synonym.
**Other names:**
Chaulmoogra, chaulmoogra oil, Hydnocarpus oil, chaulmoograte oil, hydnocarpus oil, Kalawalla oil, and, historically, *Taraktogenos* oil. The name “chaulmoogra” has also been applied more broadly to seed oils obtained from several related species of *Hydnocarpus* and other genera containing characteristic cyclopentenyl fatty acids.
**Brief introduction:**
Chaulmoogra oil is a fixed seed oil obtained principally from species of *Hydnocarpus*, tropical trees native to South and Southeast Asia. The seeds contain an unusual group of cyclopentenyl fatty acids, especially hydnocarpic, chaulmoogric, and gorlic acids. Oil from *H. wightianus*/*H. pentandrus* is among the historically important sources. Modern chemical analyses confirm that these unusual fatty acids constitute a major portion of the oil.
Chaulmoogra became one of the most important pre-antibiotic treatments for leprosy (Hansen disease). Its history extends from traditional South Asian medicine into nineteenth- and early twentieth-century Western medicine, where injections of chaulmoogra preparations became an important—although imperfect—treatment before sulfone drugs and multidrug therapy transformed leprosy treatment.
**Traditional uses:**
* Used in Ayurvedic and other South Asian medical traditions for leprosy and chronic skin disorders.
* Applied externally to skin eruptions, ulcers, wounds, and inflammatory skin conditions.
* Used traditionally for rheumatic pain, sprains, and bruising.
* Employed in traditional medicine for certain parasitic and inflammatory disorders.
* Used as a topical medicinal oil for chronic dermatological conditions.
**Historical use:**
* The use of chaulmoogra preparations for leprosy is described in association with the ancient Indian medical tradition, with references tracing its use to the *Sushruta Samhita* and approximately the sixth century BCE.
* During the nineteenth century, chaulmoogra oil became increasingly prominent in European and colonial medical literature concerning leprosy.
* In the early twentieth century, Sir Leonard Rogers investigated injectable chaulmoogra preparations and developed sodium hydnocarpate preparations for treatment of leprosy.
* Chaulmoogra oil was administered orally, topically, and by injection, although gastrointestinal intolerance made oral administration difficult and injections could be painful.
* From the 1940s onward, sulfone therapy—especially Promin and subsequently dapsone—largely displaced chaulmoogra as the principal treatment for leprosy.
**Parts used and method of use:**
* Mature seeds
* Seed oil
Used as:
* Cold- or mechanically expressed fixed oil.
* Traditionally administered orally in various preparations.
* Applied externally to affected skin.
* Historically converted into salts or esters of its fatty acids for parenteral treatment of leprosy.
**Use in healing (modern herbal practice):**
* Historically used in the treatment of leprosy before the development of effective antimicrobial chemotherapy.
* Traditionally used externally for chronic inflammatory and infectious skin disorders.
* Historical preparations were employed for ulcers, dermatitis, eczema, and other chronic skin lesions.
* Experimental research has demonstrated activity of chaulmoogra fatty acids against *Mycobacterium leprae*.
* Modern clinical practice does **not** use crude chaulmoogra oil as a primary treatment for leprosy; contemporary multidrug antimicrobial therapy has replaced it.
**Pharmacology and biochemistry:**
* **Hydnocarpic acid** — a characteristic cyclopentenyl fatty acid and one of the principal constituents of chaulmoogra oil.
* **Chaulmoogric acid** — another major cyclopentenyl fatty acid characteristic of the oil.
* **Gorlic acid** — a further cyclopentenyl fatty acid occurring in significant quantities.
The precise proportions vary considerably according to species and preparation. Analyses of *H. wightiana* oil have demonstrated that cyclopentenyl fatty acids constitute approximately 80% of the fatty-acid fraction, with hydnocarpic, chaulmoogric, and gorlic acids predominating.
Mechanisms:
* Chaulmoogric and related fatty acids demonstrate inhibitory activity against *Mycobacterium leprae* in experimental models.
* The unusual cyclopentenyl structure of these fatty acids appears to be important to their antimycobacterial activity.
* Historical evidence suggests that these fatty acids can inhibit multiplication of *M. leprae*, although their mechanism is not sufficiently characterized to treat them as equivalent to modern antimycobacterial drugs.
Overall profile:
Chaulmoogra oil is historically significant as one of the earliest substances to achieve some therapeutic effect against leprosy. Its cyclopentenyl fatty acids possess genuine antimycobacterial activity, but the crude oil was inconsistent, poorly tolerated, and substantially less effective than modern antimicrobial therapy. Its importance today is therefore principally **ethnobotanical, historical, and pharmacological**, rather than as a replacement for contemporary treatment of Hansen disease.
**Common dosage:**
* **Crude oral oil:** Historical doses varied widely; no modern standardized medicinal dosage is recommended.
* **Topical oil:** Historically applied directly to affected skin; no standardized evidence-based dosage exists.
* **Sodium hydnocarpate:** Historically administered by injection under medical supervision; dosing was preparation-specific and is obsolete as routine leprosy therapy.
* **Chaulmoogric/hydnocarpic acid preparations:** Historically administered as pharmaceutical derivatives rather than crude oil; modern self-treatment is not appropriate.
Because crude chaulmoogra preparations are obsolete for treatment of leprosy and standardized contemporary dosing is not established, **no routine internal dosage should be recommended in a modern herbal dispensatory.**
**Safety factors (including side effects):**
* Oral chaulmoogra oil may cause nausea, vomiting, abdominal discomfort, and gastrointestinal intolerance.
* Injectable preparations historically caused considerable local pain and inflammatory reactions.
* Allergic or irritant skin reactions are possible with topical application.
* Crude oils from different species are chemically variable, making historical dosage information difficult to translate into modern practice.
* Chaulmoogra oil should **not** be used as a substitute for modern multidrug therapy in suspected or confirmed leprosy.
**First aid / adverse reaction response:**
* **Nausea or vomiting:** Discontinue oral exposure, maintain hydration, and seek medical advice if severe or persistent.
* **Severe abdominal symptoms:** Stop use and obtain medical assessment.
* **Skin irritation or dermatitis:** Remove the preparation and wash the affected area with soap and water.
* **Signs of severe allergic reaction:** Seek emergency medical attention immediately.
**Drug interactions:**
* No clinically well-established modern drug-interaction profile exists for crude chaulmoogra oil.
* Historical chaulmoogra treatment should not be combined with or substituted for modern antimycobacterial treatment without specialist supervision.
* Theoretically, concentrated preparations of unusual fatty acids may interact with lipid metabolism or other fatty-acid-active medicines, although clinical significance has not been established.
* Because the oil is chemically variable and its therapeutic use is largely historical, concurrent use with prescription medicines should be discussed with a physician or pharmacist.
**Horticultural requirements:**
* **USDA / Canadian zone:** Approximately USDA Zones 10–12; tropical to subtropical conditions required. Not hardy outdoors in most of Canada.
* **Soil pH:** Approximately 5.5–7.0; prefers fertile, well-drained tropical soils.
* **Light requirements:** Full sun to partial shade.
* **Moisture:** Moderate to high moisture; benefits from humid tropical conditions but requires adequate drainage.
* **Other notes (growth habit, harvest timing, etc.):**
* **Growth habit:** Evergreen tropical tree capable of reaching substantial height under natural conditions.
* **Flowering/fruiting:** Produces flowers followed by large fruits containing numerous oil-rich seeds.
* **Harvest timing:** Mature fruits and seeds are collected when fully developed; the seeds are dried before oil extraction.
* **Habitat:** Tropical forests and humid regions of the Indian subcontinent and Southeast Asia.
* **Propagation/cultivation notes:** Propagated primarily from seed; requires warmth, humidity, and a long frost-free growing season. It is unsuitable for ordinary outdoor cultivation in Canadian climates.
**Sampling of clinical reports / studies:**
* **Clinical/historical study:** Early twentieth-century clinical work by Leonard Rogers investigated chaulmoogra oil and its derivatives in leprosy, leading to sodium hydnocarpate and related injectable preparations.
* **Pharmacological study:** Experimental work demonstrated that chaulmoogra fatty acids inhibited multiplication of *Mycobacterium leprae* in mouse-footpad models, providing experimental support for its historical antileprosy reputation.
* **Phytochemical study:** Chemical analyses demonstrate that chaulmoogra oil is unusually rich in cyclopentenyl fatty acids, particularly hydnocarpic, chaulmoogric, and gorlic acids. A 2025 analysis of *H. wightiana* oil found approximately 80% of the fatty-acid fraction consisted of cyclopentenyl fatty acids.
* **Ethnobotanical evidence:** Traditional Indian medical literature documents chaulmoogra preparations for leprosy and chronic dermatological disorders, while related *Hydnocarpus* species have been used throughout South and Southeast Asia for skin diseases and other conditions.
* **Overall assessment of evidence:** Chaulmoogra has an unusually strong historical connection between traditional medicine, pharmacognosy, laboratory investigation, and early modern clinical medicine. Its antimycobacterial activity is genuine, but its therapeutic limitations and poor tolerability led to its replacement by sulfone drugs and ultimately multidrug antimicrobial therapy. It should therefore be presented in a modern materia medica primarily as a **historically important antileprosy medicine and source of pharmacologically unusual fatty acids**, not as a contemporary treatment for Hansen disease.
Educational Use Only: The information presented on this page is provided for educational, historical, and informational purposes only. ArdNemeton na Tuatha and Bhùth Draoi do not provide medical advice. Always consult your physician and pharmacist before using any herb, mushroom, supplement, or botanical product for medicinal purposes. Traditional uses described herein do not constitute medical claims.